This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: National Institute of Radiological Sciences, Canon Medical Systems Corporation, General Incorporated Association the Japan-Multinational Trial Organization. Active years: 2005-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 61 
1 out of 1,350 
1 out of 1 
Years Active: 2005-2022
Title: The Innovations of Ming-Rong Zhang
Introduction
Ming-Rong Zhang is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of nuclear medicine and radiopharmaceuticals. With a total of 3 patents, his work focuses on innovative analysis apparatuses and compounds that enhance cancer treatment methodologies.
Latest Patents
One of his latest patents is an analysis apparatus and analysis program designed to evaluate the accumulation of radiolabeled anticancer drugs in tumor regions. This apparatus includes an extraction unit that retrieves detection values from various regions, a calculation unit that computes comparison values, and an evaluation unit that assesses drug accumulation based on these values. Another patent involves the synthesis of a phenyl tin compound using a bromo- or iodo-benzene ring as a labeling material for a radioactive ligand. This innovative process also leads to the creation of a novel hydroxytosyl iodobenzene compound, which is synthesized through oxidation and reaction with tosylic acid.
Career Highlights
Ming-Rong Zhang has worked with esteemed organizations such as the National Institute of Radiological Sciences and Taisho Pharmaceutical Co., Ltd. His experience in these institutions has allowed him to develop and refine his inventions, contributing to advancements in medical technology.
Collaborations
Throughout his career, Ming-Rong Zhang has collaborated with notable colleagues, including Kazutoshi Suzuki and Tetsuya Suhara. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.
Conclusion
Ming-Rong Zhang's contributions to the field of nuclear medicine and his innovative patents demonstrate his commitment to improving cancer treatment technologies. His work continues to influence the development of effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile